Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term management of symptomatic uterine fibroids with ulipristal acetate 5 mg or 10 mg
2012-000036-26Phase 3Completed
- Sponsor
- PregLem
- Start
- Apr 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ulipristal in Fibromyoma (LM) (2 arms), sponsored by PregLem. Primary endpoint: Primary endpoint Part I. Started Apr 2012; status: completed.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on 2012-000036-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000036-26.